Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4125)
All Articles published online
|
Apr 15, 2004 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shi M, Zhang B, Tang ZR, Lei ZY, Wang HF, Feng YY, Fan ZP, Xu DP, Wang FS. Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma. World J Gastroenterol 2004; 10(8): 1146-1151 [PMID: 15069715 DOI: 10.3748/wjg.v10.i8.1146] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i8/1146.htm |
| Number | Citing Articles |
| 1 |
Bo Yang, Xue‐chun Lu, Rui‐li Yu, Xiao‐hua Chi, Yang Liu, Yao Wang, Han‐ren Dai, Hong‐li Zhu, Li‐li Cai, Wei‐dong Han. Repeated transfusions of autologous cytokine‐induced killer cells for treatment of haematological malignancies in elderly patients: a pilot clinical trial. Hematological Oncology 2012; 30(3): 115 doi: 10.1002/hon.1012
|
| 2 |
Kenneth B. DeSantes, Paul M. Sondel. Oncology of Infancy and Childhood. 2009; : 209 doi: 10.1016/B978-1-4160-3431-5.00007-8
|
| 3 |
QI DENG, XUE BAI, HAI-RONG LV, XIA XIAO, MING-FENG ZHAO, YU-MING LI. Anti-CD20 antibody induces the improvement of cytokine-induced killer cell activity via the STAT and MAPK/ERK signaling pathways. Experimental and Therapeutic Medicine 2015; 9(4): 1215 doi: 10.3892/etm.2015.2264
|
| 4 |
Jianhua Liu, Lu Wang, Yaoling Wang, Wenjie Zhang, Yilin Cao, Tao Lu. Phenotypic characterization and anticancer capacity of CD8+ cytokine-induced killer cells after antigen-induced expansion. PLOS ONE 2017; 12(4): e0175704 doi: 10.1371/journal.pone.0175704
|
| 5 |
Maria Tagliamonte, Annacarmen Petrizzo, Maria Napolitano, Antonio Luciano, Claudio Arra, Piera Maiolino, Francesco Izzo, Maria Lina Tornesello, Luigi Aurisicchio, Gennaro Ciliberto, Franco M. Buonaguro, Luigi Buonaguro. Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model. Cancer Immunology, Immunotherapy 2015; 64(10): 1305 doi: 10.1007/s00262-015-1698-0
|
| 6 |
Sharmilan Thanendrarajan, Young Kim, Ingo Schmidt-Wolf. New adoptive immunotherapy strategies for solid tumours with CIK cells. Expert Opinion on Biological Therapy 2012; 12(5): 565 doi: 10.1517/14712598.2012.668879
|
| 7 |
Clara E. Jäkel, Annabelle Vogt, Maria A. Gonzalez-Carmona, Ingo G. H. Schmidt-Wolf. Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Gastrointestinal Tumors. Journal of Immunology Research 2014; 2014: 1 doi: 10.1155/2014/897214
|
| 8 |
Hui Zhao, Min Zheng, Kun Wang, Lianmin Wang, Haiyu He, Meilian Wang, Yanmei Shi, Songquan Huang, Fengming Ji, Xiao Li, Hong Zhu, Lin Wang, Xiaowen Zhang, Xueyang Shi, Songling Zhao, Bimang Fu, Tao Wu. A meta-analysis of adoptive immunotherapy in postoperative hepatocellular carcinoma. Journal of Cancer Research and Therapeutics 2018; 14(4): 807 doi: 10.4103/jcrt.JCRT_858_17
|
| 9 |
Philipp Heumann, Andreas Albert, Karsten Gülow, Deniz Tümen, Martina Müller, Arne Kandulski. Insights in Molecular Therapies for Hepatocellular Carcinoma. Cancers 2024; 16(10): 1831 doi: 10.3390/cancers16101831
|
| 10 |
Harriet Roddy, Tim Meyer, Claire Roddie. Novel Cellular Therapies for Hepatocellular Carcinoma. Cancers 2022; 14(3): 504 doi: 10.3390/cancers14030504
|
| 11 |
Deepa S Mandlik, Satish K Mandlik, Heena B Choudhary. Immunotherapy for hepatocellular carcinoma: Current status and future perspectives. World Journal of Gastroenterology 2023; 29(6): 1054-1075 doi: 10.3748/wjg.v29.i6.1054
|
| 12 |
Jia-hua Zhang, Li-qiong Liu, Yan-li He, Wei-jia Kong, Shi-ang Huang. Cytotoxic effect of trans-cinnamaldehyde on human leukemia K562 cells. Acta Pharmacologica Sinica 2010; 31(7): 861 doi: 10.1038/aps.2010.76
|
| 13 |
Yu-Chen Li, Lin Zhao, Jiang-Ping Wu, Chen-Xu Qu, Qing-Kun Song, Rui-Bin Wang. Cytokine-induced killer cell infusion combined with conventional treatments produced better prognosis for hepatocellular carcinoma patients with barcelona clinic liver cancer B or earlier stage: A systematic review and meta-analysis. Cytotherapy 2016; 18(12): 1525 doi: 10.1016/j.jcyt.2016.09.002
|
| 14 |
Jinying Zhang, Lingjun Zhu, Juan Wei, Lingxiang Liu, Yongmei Yin, Yanhong Gu, Yongqian Shu. The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: a clinical retrospective study. Journal of Cancer Research and Clinical Oncology 2012; 138(6): 1057 doi: 10.1007/s00432-012-1179-1
|
| 15 |
Giulia Mesiano, Maja Todorovic, Loretta Gammaitoni, Valeria Leuci, Lidia Giraudo Diego, Fabrizio Carnevale-Schianca, Franca Fagioli, Wanda Piacibello, Massimo Aglietta, Dario Sangiolo. Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors. Expert Opinion on Biological Therapy 2012; 12(6): 673 doi: 10.1517/14712598.2012.675323
|
| 16 |
Adisak Wongkajornsilp, Theera Somchitprasert, Raywadee Butraporn, Valla Wamanuttajinda, Kanda Kasetsinsombat, Sukit Huabprasert, Kittipong Maneechotesuwan, Suradej Hongeng. Human Cytokine-Induced Killer Cells Specifically Infiltrated and Retarded the Growth of the Inoculated Human Cholangiocarcinoma Cells in SCID Mice. Cancer Investigation 2009; 27(2): 140 doi: 10.1080/07357900802189832
|
| 17 |
J.-H. Zhong, L. Ma, L.-C. Wu, W. Zhao, W.-P. Yuan, F.-X. Wu, Z.-M. Zhang, S. Huang, X. M. You, L.-Q. Li. Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review. International Journal of Clinical Practice 2012; 66(1): 21 doi: 10.1111/j.1742-1241.2011.02814.x
|
| 18 |
Luigi Buonaguro. Developments in cancer vaccines for hepatocellular carcinoma. Cancer Immunology, Immunotherapy 2016; 65(1): 93 doi: 10.1007/s00262-015-1728-y
|
| 19 |
Jinying Zhang, Lingjun Zhu, Haina Du, Xiang He, Yongmei Yin, Yanhong Gu, Lianke Liu, Kaihua Lu, Renhua Guo, Ping Liu, Yongqian Shu. Autologous cytokine-induced killer cell therapy in lung cancer patients: A retrospective study. Biomedicine & Pharmacotherapy 2015; 70: 248 doi: 10.1016/j.biopha.2014.12.025
|
| 20 |
Seok-Gu Kang, Sin Soo Jeun, Jung Yeon Lim, Do Sung Yoo, Pil Woo Huh, Kyung Souk Cho, Dal Soo Kim, Hyung-Jin Shin, Jong Hyun Kim, Moon Chan Kim, Joon Ki Kang. Cytotoxicity of rat marrow stromal cells against malignant glioma cells. Child's Nervous System 2005; 21(7): 528 doi: 10.1007/s00381-005-1216-3
|
| 21 |
Xin-Yuan Liu, Guang-Wen Wei, Dong-Qin Yang, Lun-Xu Liu, Lin Ma, Xiao Li, Jian OuYang, Cui-Ping Li, Kang-Jian Zhang, Jian Wang, Liang Chu, Jin-Fa Gu, Huang-Guang Li, Jian Ding, Na Wei, Ying Cai, Xin-Ran Liu, Xin Cao, Yi Chen, Zhi-Jiang Wu, Miao Ding, Ming Zuo. Recent Advances in Cancer Research and Therapy. 2012; : 617 doi: 10.1016/B978-0-12-397833-2.00021-2
|
| 22 |
Nobuhiro Tsuchiya, Yu Sawada, Itaru Endo, Yasushi Uemura, Tetsuya Nakatsura. Potentiality of immunotherapy against hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(36): 10314-10326 doi: 10.3748/wjg.v21.i36.10314
|
| 23 |
D Sangiolo, G Mesiano, F Carnevale-Schianca, W Piacibello, M Aglietta, A Cignetti. Cytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantation. Expert Opinion on Biological Therapy 2009; 9(7): 831 doi: 10.1517/14712590903005552
|
| 24 |
Qiang Gao, Yinghong Shi, Xiaoying Wang, Jian Zhou, Shuangjian Qiu, Jia Fan. Translational medicine in hepatocellular carcinoma. Frontiers of Medicine 2012; 6(2): 122 doi: 10.1007/s11684-012-0193-7
|
| 25 |
Lifeng Wang, Fu-Sheng Wang. Clinical immunology and immunotherapy for hepatocellular carcinoma: current progress and challenges. Hepatology International 2019; 13(5): 521 doi: 10.1007/s12072-019-09967-y
|
| 26 |
Hongmin Wang, Yuzhong Cui, Sheng Wang, Rusen Zhao, Ming Sun. Curative Effects of Dendritic Cells Combined with Cytokine-Induced Killer Cells in Patients with Malignant Pericardial Effusion. Medical Science Monitor 2016; 22: 4159 doi: 10.12659/MSM.897657
|
| 27 |
Alice Pievani, Gianmaria Borleri, Daniela Pende, Lorenzo Moretta, Alessandro Rambaldi, Josée Golay, Martino Introna. Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity. Blood 2011; 118(12): 3301 doi: 10.1182/blood-2011-02-336321
|
| 28 |
Ying Wang, Zenghui Xu, Fuping Zhou, Yan Sun, Jingbo Chen, Linfang Li, Huajun Jin, Qijun Qian. The combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors. Experimental Hematology & Oncology 2015; 4(1) doi: 10.1186/s40164-015-0027-9
|
| 29 |
Xiao-Dong Li, Bin Xu, Jun Wu, Mei Ji, Bei-Hua Xu, Jing-Ting Jiang, Chang-Ping Wu. Review of Chinese clinical trials on CIK cell treatment for malignancies. Clinical and Translational Oncology 2012; 14(2): 102 doi: 10.1007/s12094-012-0768-4
|
| 30 |
Yu Chen, Gen Lin, Zeng-qing Guo, Zhi-feng Zhou, Zhi-yong He, Yun-bin Ye, Alfons Navarro. Effects of MICA Expression on the Prognosis of Advanced Non-Small Cell Lung Cancer and the Efficacy of CIK Therapy. PLoS ONE 2013; 8(7): e69044 doi: 10.1371/journal.pone.0069044
|
| 31 |
Angela R. Elia, Paola Circosta, Dario Sangiolo, Chiara Bonini, Loretta Gammaitoni, Sara Mastaglio, Pietro Genovese, Massimo Geuna, Fabio Avolio, Giorgio Inghirami, Corrado Tarella, Alessandro Cignetti. Cytokine-Induced Killer Cells Engineered with Exogenous T-Cell Receptors Directed Against Melanoma Antigens: Enhanced Efficacy of Effector Cells Endowed with a Double Mechanism of Tumor Recognition. Human Gene Therapy 2015; 26(4): 220 doi: 10.1089/hum.2014.112
|
| 32 |
Shahe Boghossian, Stuart Robinson, Alexei Von Delwig, Derek Manas, Steve White. Immunotherapy for treating metastatic colorectal cancer. Surgical Oncology 2012; 21(2): 67 doi: 10.1016/j.suronc.2010.10.004
|
| 33 |
Jing Wang, Lingxin Feng, Linwei Zhang. Combining cellular immunotherapy was an optional choice for unresectable advanced HCC: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2021; 45(1): 101440 doi: 10.1016/j.clinre.2020.04.010
|
| 34 |
Chou-Yi Hsu, Mohammed Ahmed Mustafa, Ashwani Kumar, Atreyi Pramanik, Rajiv Sharma, Faraj Mohammed, Israa Abed Jawad, Imad Jasim Mohammed, Mohammad Y. Alshahrani, Noor Alhuda Mohammad Ali khalil, Ali Turki Shnishil, Munther Kadhim Abosaoda. Exploiting the immune system in hepatic tumor targeting: Unleashing the potential of drugs, natural products, and nanoparticles. Pathology - Research and Practice 2024; 256: 155266 doi: 10.1016/j.prp.2024.155266
|
| 35 |
Xiao-Dong Li, Mei Ji, Xiao Zheng, Zhong-Hua Ning, Jun Wu, Binfeng Lu, Chang-Ping Wu, Jing-Ting Jiang. Evaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors. Journal of Translational Medicine 2014; 12(1) doi: 10.1186/s12967-014-0215-0
|
| 36 |
Fatemeh Afra, Amir Ali Mahboobipour, Amir Salehi Farid, Moein Ala. Recent progress in the immunotherapy of hepatocellular carcinoma: Non-coding RNA-based immunotherapy may improve the outcome. Biomedicine & Pharmacotherapy 2023; 165: 115104 doi: 10.1016/j.biopha.2023.115104
|
| 37 |
M. Ohira, S. Nishida, T. Matsuura, I. Muraoka, P. Tryphonopoulos, J. Fan, A. Tekin, G. Selvaggi, D. Levi, P. Ruiz, C. Ricordi, H. Ohdan, A.G. Tzakis. Comparative Analysis of T-Cell Depletion Method for Clinical Immunotherapy—Anti–Hepatitis C Effects of Natural Killer Cells Via Interferon-γ Production. Transplantation Proceedings 2013; 45(5): 2045 doi: 10.1016/j.transproceed.2013.01.046
|
| 38 |
Ke Pan, Yong-Qiang Li, Wei Wang, Li Xu, Yao-Jun Zhang, Hai-Xia Zheng, Jing-Jing Zhao, Hui-Juan Qiu, De-Sheng Weng, Jian-Jun Li, Qi-Jing Wang, Li-Xi Huang, Jia He, Shi-Ping Chen, Miao-La Ke, Pei-Hong Wu, Min-Shan Chen, Sheng-Ping Li, Jian-Chuan Xia, Yi-Xin Zeng. The Efficacy of Cytokine-Induced Killer Cell Infusion as an Adjuvant Therapy for Postoperative Hepatocellular Carcinoma Patients. Annals of Surgical Oncology 2013; 20(13): 4305 doi: 10.1245/s10434-013-3144-x
|
| 39 |
M Introna, M Franceschetti, A Ciocca, G Borleri, E Conti, J Golay, A Rambaldi. Rapid and massive expansion of cord blood-derived cytokine-induced killer cells: an innovative proposal for the treatment of leukemia relapse after cord blood transplantation. Bone Marrow Transplantation 2006; 38(9): 621 doi: 10.1038/sj.bmt.1705503
|
| 40 |
Sharmilan Thanendrarajan, Michael Nowak, Hinrich Abken, Ingo G.H. Schmidt-Wolf. Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: More than one plus one?. Leukemia Research 2011; 35(9): 1136 doi: 10.1016/j.leukres.2011.05.005
|
| 41 |
Haiqing Wang, Aixiang Liu, Wentao Bo, Xielin Feng, Yong Hu, Lang Tian, Hui Zhang, Xiaoli Tang. Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma patients after curative resection, a systematic review and meta-analysis. Digestive and Liver Disease 2016; 48(11): 1275 doi: 10.1016/j.dld.2016.07.010
|
| 42 |
B??atrice Cl??menceau, G??raldine Gallot, R??gine Vivien, Jo??lle Gaschet, Mario Campone, Henri Vi??. Long-Term Preservation of Antibody-Dependent Cellular Cytotoxicity (ADCC) of Natural Killer Cells Amplified In Vitro From the Peripheral Blood of Breast Cancer Patients After Chemotherapy. Journal of Immunotherapy 2006; 29(1): 53 doi: 10.1097/01.cji.0000175686.13368.5c
|
| 43 |
Xue-chun Lu, Bo Yang, Rui-li Yu, Xiao-hua Chi, Shuai Tuo, Chao-wei Tuo, Hong-li Zhu, Yao Wang, Chao-guang Jiang, Xiao-bing Fu, Yang Yang, Yang Liu, Shan-qian Yao, Han-ren Dai, Li-li Cai, Bing-jun Li, Wei-dong Han. Clinical Study of Autologous Cytokine-Induced Killer Cells for the Treatment of Elderly Patients with Diffuse Large B-Cell Lymphoma. Cell Biochemistry and Biophysics 2012; 62(1): 257 doi: 10.1007/s12013-011-9273-6
|
| 44 |
Elisabetta Cariani, Gabriele Missale. Immunotherapy of Hepatocellular Carcinoma. 2017; : 19 doi: 10.1007/978-3-319-64958-0_2
|
| 45 |
Alice Pievani, Camilla Belussi, Christian Klein, Alessandro Rambaldi, Josée Golay, Martino Introna. Enhanced killing of human B-cell lymphoma targets by combined use of cytokine-induced killer cell (CIK) cultures and anti-CD20 antibodies. Blood 2011; 117(2): 510 doi: 10.1182/blood-2010-06-290858
|
| 46 |
Jesús Prieto, Ignacio Melero, Bruno Sangro. Immunological landscape and immunotherapy of hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology 2015; 12(12): 681 doi: 10.1038/nrgastro.2015.173
|
| 47 |
JINGYI LIU, JUN SUI, ZHIWEI ZHANG, XIUBAO REN, LI LUAN, QISHENG YANG, SONGHAI GU, RUDOLF WANK, BARBARA LAUMBACHER, XIN SONG. Inhibition of pleural metastasis of collecting duct carcinoma of the kidney by modified cytokine-induced killer cells: A case report and review of the literature. Oncology Letters 2010; 1(6): 955 doi: 10.3892/ol.2010.168
|
| 48 |
Hao Peng, Meng Yao, Hongwei Fan, Liwei Song, Jinwen Sun, Zheng Zhou, Yunfeng Du, Keyu Lu, Tao Li, Aiguo Yin, Jianhua Xu, Shidong Wei. Effects of Autologous Cytokine-Induced Killer Cells Infusion in Colorectal Cancer Patients: A Prospective Study. Cancer Biotherapy and Radiopharmaceuticals 2017; 32(6): 221 doi: 10.1089/cbr.2017.2246
|
| 49 |
Tim F. Greten, Michael P. Manns, Firouzeh Korangy. Immunotherapy of hepatocellular carcinoma. Journal of Hepatology 2006; 45(6): 868 doi: 10.1016/j.jhep.2006.09.004
|
| 50 |
Zusheng Yu, Guowei Li, Hang Yu, Tetsuya Asakawa. Changes of immune cells in patients with hepatocellular carcinoma treated by radiofrequency ablation and hepatectomy, a pilot study. Open Life Sciences 2021; 16(1): 1002 doi: 10.1515/biol-2021-0105
|
| 51 |
M Shi, S Qian, W-W Chen, H Zhang, B Zhang, Z-R Tang, Z Zhang, F-S Wang. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responsesin vitro. Clinical and Experimental Immunology 2007; 147(2): 277 doi: 10.1111/j.1365-2249.2006.03281.x
|
| 52 |
Liangrong Shi, Qi Zhou, Jun Wu, Mei Ji, Guojun Li, Jingting Jiang, Changping Wu. Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer. Cancer Immunology, Immunotherapy 2012; 61(12): 2251 doi: 10.1007/s00262-012-1289-2
|
| 53 |
C. Hontscha, Y. Borck, H. Zhou, D. Messmer, I. G. H. Schmidt-Wolf. Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC). Journal of Cancer Research and Clinical Oncology 2011; 137(2): 305 doi: 10.1007/s00432-010-0887-7
|
| 54 |
Abid Ali Khan, Zhi-Kun Liu, Xiao Xu. Recent advances in immunotherapy for hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2021; 20(6): 511 doi: 10.1016/j.hbpd.2021.06.010
|
| 55 |
Jin Lee, Kye-Taek Lim. SJSZ glycoprotein (38 kDa) prevents thymus atrophy and enhances expression of IL-2 and IL-12 in diethylnitrosamine-induced hepatocarcinogenesis. International Immunopharmacology 2012; 13(3): 362 doi: 10.1016/j.intimp.2012.04.018
|
| 56 |
Jennifer L. Giglia, Scott J. Antonia, Lawrence B. Berk, Salvador Bruno, Sophie Dessureault, Steven E. Finkelstein. Systemic Therapy for Advanced Hepatocellular Carcinoma: Past, Present, and Future. Cancer Control 2010; 17(2): 120 doi: 10.1177/107327481001700207
|
| 57 |
Virna Marin, Erica Dander, Ettore Biagi, Martino Introna, Grazia Fazio, Andrea Biondi, Giovanna D'Amico. Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy. Experimental Hematology 2006; 34(9): 1218 doi: 10.1016/j.exphem.2006.05.004
|
| 58 |
Paola Olioso, Raffaella Giancola, Maria Di Riti, Alessandro Contento, Patrizia Accorsi, Antonio Iacone. Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trial. Hematological Oncology 2009; 27(3): 130 doi: 10.1002/hon.886
|
| 59 |
Guozheng Liang, Gang Feng, Hui Chen, Ling Li, Jicong Hu, Chuandong Zhou, Jiawen Li, Han Shen, Fenglin Wu, Changli Tao, Yan Liu, Wenfeng Zhang, Hongwei Shao. Changes in the TCR repertoire of T‐cell subsets during culture of cytokine‐induced killer cells. FEBS Letters 2022; 596(20): 2696 doi: 10.1002/1873-3468.14501
|
| 60 |
Luigi Buonaguro, Annacarmen Petrizzo, Maria Tagliamonte, Maria Lina Tornesello, Franco M. Buonaguro. Challenges in cancer vaccine development for hepatocellular carcinoma. Journal of Hepatology 2013; 59(4): 897 doi: 10.1016/j.jhep.2013.05.031
|
| 61 |
Fares E.M. Ali, Islam M. Ibrahim, Hanan S. Althagafy, Emad H.M. Hassanein. Role of immunotherapies and stem cell therapy in the management of liver cancer: A comprehensive review. International Immunopharmacology 2024; 132: 112011 doi: 10.1016/j.intimp.2024.112011
|
| 62 |
Ming Shi, Junliang Fu, Feng Shi, Bin Zhang, Zirong Tang, Lei Jin, Zhenping Fan, Zheng Zhang, Liming Chen, Huifeng Wang, George K.K. Lau, Fu-Sheng Wang. Transfusion of autologous cytokine-induced killer cells inhibits viral replication in patients with chronic hepatitis B virus infection. Clinical Immunology 2009; 132(1): 43 doi: 10.1016/j.clim.2009.03.001
|
| 63 |
Leonard Christopher Schmeel, Frederic Carsten Schmeel, Christoph Coch, Ingo G. H. Schmidt-Wolf. Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC). Journal of Cancer Research and Clinical Oncology 2015; 141(5): 839 doi: 10.1007/s00432-014-1864-3
|
| 64 |
Dario Sangiolo, Emanuela Martinuzzi, Maja Todorovic, Katiuscia Vitaggio, Antonella Vallario, Noela Jordaney, Fabrizio Carnevale-Schianca, Antonio Capaldi, Massimo Geuna, Laura Casorzo, Richard A. Nash, Massimo Aglietta, Alessandro Cignetti. Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers. International Immunology 2008; 20(7): 841 doi: 10.1093/intimm/dxn042
|
| 65 |
Yong Zhang, Yu’nan Zhu, Erjiang Zhao, Xiaolei He, Lingdi Zhao, Zibing Wang, Xiaomin Fu, Yalong Qi, Baozhen Ma, Yongping Song, Quanli Gao. Autologous Cytokine-Induced Killer Cell Immunotherapy May Improve Overall Survival in Advanced Malignant Melanoma Patients. Immunotherapy 2017; 9(14): 1165 doi: 10.2217/imt-2017-0061
|
| 66 |
Fu‐Sheng Wang. Clinical immune characterization of hepatitis B virus infection and implications for immune intervention: Progress and challenges. Hepatology Research 2007; 37(s3) doi: 10.1111/j.1872-034X.2007.00222.x
|
| 67 |
Kwan-Hwa Chi, Shih-Jen Liu, Chung-Pin Li, Hsu-Ping Kuo, Yu-Shan Wang, Yee Chao, Shih-Liang Hsieh. Combination of Conformal Radiotherapy and Intratumoral Injection of Adoptive Dendritic Cell Immunotherapy in Refractory Hepatoma. Journal of Immunotherapy 2005; 28(2): 129 doi: 10.1097/01.cji.0000154248.74383.5e
|
| 68 |
Chunsheng Liu, Lukkana Suksanpaisan, Yun-Wen Chen, Stephen J. Russell, Kah-Whye Peng. Enhancing cytokine-induced killer cell therapy of multiple myeloma. Experimental Hematology 2013; 41(6): 508 doi: 10.1016/j.exphem.2013.01.010
|
| 69 |
Pan Jiang, Yan Zhang, Steve J Archibald, Hua Wang. Adoptive cell transfer after chemotherapy enhances survival in patients with resectable HNSCC. International Immunopharmacology 2015; 28(1): 208 doi: 10.1016/j.intimp.2015.05.042
|
| 70 |
TAO WU, CÉLINE LEBOEUF, SARAH DURAND, BIN SU, MARINA DESCHAMPS, XIAOWEN ZHANG, CHRISTOPHE FERRAND, PATRICK PESSAUX, ERIC ROBINET. Suicide gene-modified killer cells as an allogeneic alternative to autologous cytokine-induced killer cell immunotherapy of hepatocellular carcinoma. Molecular Medicine Reports 2016; 13(3): 2645 doi: 10.3892/mmr.2016.4811
|
| 71 |
C. Rössig, G. Weber, E. Rettinger. T-Zell-Therapien bei Leukämie. Monatsschrift Kinderheilkunde 2010; 158(3): 232 doi: 10.1007/s00112-009-2140-5
|
| 72 |
De-Sheng Weng, Jun Zhou, Qi-Ming Zhou, Ming Zhao, Qi-Jing Wang, Li-Xi Huang, Yong-Qiang Li, Shi-Ping Chen, Pei-Hong Wu, Jian-Chuan Xia. Minimally Invasive Treatment Combined With Cytokine-induced Killer Cells Therapy Lower the Short-term Recurrence Rates of Hepatocellular Carcinomas. Journal of Immunotherapy 2008; 31(1): 63 doi: 10.1097/CJI.0b013e31815a121b
|
| 73 |
Marta Franceschetti, Alice Pievani, Gianmaria Borleri, Luca Vago, Katharina Fleischhauer, Josée Golay, Martino Introna. Cytokine-induced killer cells are terminallydifferentiated activated CD8 cytotoxic T-EMRA lymphocytes. Experimental Hematology 2009; 37(5): 616 doi: 10.1016/j.exphem.2009.01.010
|
| 74 |
Baofu Zhang, Weina Zhao, Huizhong Li, Yuanyuan Chen, Hui Tian, Liantao Li, Longzhen Zhang, Chao Gao, Junnian Zheng. Immunoreceptor TIGIT inhibits the cytotoxicity of human cytokine-induced killer cells by interacting with CD155. Cancer Immunology, Immunotherapy 2016; 65(3): 305 doi: 10.1007/s00262-016-1799-4
|
| 75 |
Ming Shi, Junliang Fu, Feng Shi, Bin Zhang, Zirong Tang, Zheng Zhang, Hui Zhang, Lei Jin, Liming Chen, Huifeng Wang, Sheikh Mohammad Fazle Akbar, Fu‐Sheng Wang. Viral suppression correlates with dendritic cell restoration in chronic hepatitis B patients with autologous cytokine‐induced killer cell transfusion. Liver International 2009; 29(3): 466 doi: 10.1111/j.1478-3231.2008.01861.x
|
| 76 |
Chen Yang, Hailin Zhang, Linmeng Zhang, Andrew X. Zhu, René Bernards, Wenxin Qin, Cun Wang. Evolving therapeutic landscape of advanced hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology 2023; 20(4): 203 doi: 10.1038/s41575-022-00704-9
|
| 77 |
Jane Kelly-Rogers, Laura Madrigal-Estebas, Tony O’Connor, Derek G. Doherty. Activation-Induced Expression of CD56 by T Cells Is Associated With a Reprogramming of Cytolytic Activity and Cytokine Secretion Profile In Vitro. Human Immunology 2006; 67(11): 863 doi: 10.1016/j.humimm.2006.08.292
|
| 78 |
Arashar Arafar. Cytokine induced killer cell immunotherapy in cancer treatment: from bench to bedside. Biomedical Research and Therapy 2014; 1(2) doi: 10.7603/s40730-014-0012-7
|
| 79 |
Haitao Wang, Bo Yang, Xiaohua Chi, Lili Cai, Ruili Yu, Hongli Zhu, Shuai Tuo, Feng Zhang, Xuanchi Wang, Yang Yang, Xiaoxiong Wu, Songwei Li, Xuechun Lu. Ultra-Low-Dose Decitabine Combined With Autologous Cytokine-Induced Killer Cells for Elderly Patients With Acute Myeloid Leukemia Transformed From Myelodysplastic Syndrome. Clinical Therapeutics 2014; 36(7): 1104 doi: 10.1016/j.clinthera.2014.05.065
|
| 80 |
Hui Liu, Jianyu Li, Fengmei Wang, Yingtang Gao, Ying Luo, Peng Wang, Chenglong Li, Zhengyan Zhu. Comparative study of different procedures for the separation of peripheral blood mononuclear cells in cytokine-induced killer cell immunotherapy for hepatocarcinoma. Tumor Biology 2015; 36(4): 2299 doi: 10.1007/s13277-014-2837-5
|
| 81 |
Ying Qiu, Mark M. Yun, Ming Bao Xu, Yi Zhong Wang, Sheng Yun. Pancreatic carcinoma-specific immunotherapy using synthesised alpha-galactosyl epitope-activated immune responders: findings from a pilot study. International Journal of Clinical Oncology 2013; 18(4): 657 doi: 10.1007/s10147-012-0434-4
|
| 82 |
Xiao Liang, Xiang Hu, Yue Hu, Weijie Zeng, Guifang Zeng, Yuan Ren, Yuncheng Liu, Kangzhuo Chen, Hao Peng, Hailei Ding, Muyun Liu. Recovery and functionality of cryopreserved peripheral blood mononuclear cells using five different xeno-free cryoprotective solutions. Cryobiology 2019; 86: 25 doi: 10.1016/j.cryobiol.2019.01.004
|
| 83 |
Ran Chen, Xin Deng, Haochen Wu, Peichun Peng, Bin Wen, Fuyin Li, Fenfen Li. Combined immunotherapy with dendritic cells and cytokine-induced killer cells for malignant tumors: A systematic review and meta-analysis. International Immunopharmacology 2014; 22(2): 451 doi: 10.1016/j.intimp.2014.07.019
|
| 84 |
Runbo Zhong, Jiajun Teng, Baohui Han, Hua Zhong. Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer. Cancer Immunology, Immunotherapy 2011; 60(10): 1497 doi: 10.1007/s00262-011-1060-0
|
| 85 |
Yin Li, Ke Pan, Li-zhi Liu, Yong-qiang Li, Mo-fa Gu, Hua Zhang, Wei-xi Shen, Jian-chuan Xia, Jian-jun Li, Pierre Busson. Sequential Cytokine-Induced Killer Cell Immunotherapy Enhances the Efficacy of the Gemcitabine Plus Cisplatin Chemotherapy Regimen for Metastatic Nasopharyngeal Carcinoma. PLOS ONE 2015; 10(6): e0130620 doi: 10.1371/journal.pone.0130620
|
| 86 |
Zhuoyan Liu, Xuan Liu, Jiaxin Liang, Yixin Liu, Xiaorui Hou, Meichuan Zhang, Yongyin Li, Xiaotao Jiang. Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.765101
|
| 87 |
Fanping Meng, Jinfang Zhao, Anthony Tanoto Tan, Wei Hu, Si-Yu Wang, Jiehua Jin, Juan Wu, Yuanyuan Li, Lei Shi, Jun-Liang Fu, Shuangjie Yu, Yingjuan Shen, Limin Liu, Junqing Luan, Ming Shi, Yunbo Xie, Chun-Bao Zhou, Regina Wanju Wong, Wai Lu-En, Sarene Koh, Antonio Bertoletti, Tingting Wang, Ji-Yuan Zhang, Fu-Sheng Wang. Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial. Hepatology International 2021; 15(6): 1402 doi: 10.1007/s12072-021-10250-2
|
| 88 |
Derek G. Doherty. Immunity, tolerance and autoimmunity in the liver: A comprehensive review. Journal of Autoimmunity 2016; 66: 60 doi: 10.1016/j.jaut.2015.08.020
|
| 89 |
Yelei Guo, Weidong Han. Cytokine-induced killer (CIK) cells: from basic research to clinical translation. Chinese Journal of Cancer 2015; 34(3) doi: 10.1186/s40880-015-0002-1
|
| 90 |
Sidhartha Tavri, Priyanka Jha, Reinhard Meier, Tobias D. Henning, Tina Müller, Daniel Hostetter, Christiane Knopp, Magnus Johansson, Verena Reinhart, Sophie Boddington, Akhilesh Sista, Winfried S. Wels, Heike E. Daldrup-Link. Optical Imaging of Cellular Immunotherapy against Prostate Cancer. Molecular Imaging 2009; 8(1) doi: 10.2310/7290.2009.00002
|
| 91 |
Jinpu Yu, Xiubao Ren, Shui Cao, Weihong Zhang, Xishan Hao. Th1 Polarization and Apoptosis-Inducing Activity of CD4+T -Cells in Cytokine-Induced Killers Might Favor the Antitumor Cytotoxicity of Cytokine-Induced KillersIn Vivo. Cancer Biotherapy and Radiopharmaceuticals 2006; 21(3): 276 doi: 10.1089/cbr.2006.21.276
|
| 92 |
YANYAN PAN, YUANYUAN WU, JUN JI, HONGJIAO CAI, HESHUANG WANG, YIFAN JIANG, LIMIN SANG, JIN YANG, YANYAN GAO, YING LIU, LIANGWEI YIN, LI ZHANG. Effect of cytokine-induced killer cells on immune function in patients with lung cancer. Oncology Letters 2016; 11(4): 2827 doi: 10.3892/ol.2016.4284
|
| 93 |
Kyung Won Park, Tae Hoon Park, Eun Ji Jang, Pil Soo Sung. Recent Advances in Immune-based Therapy for Hepatocellular Carcinoma. Journal of Digestive Cancer Research 2024; 12(2): 115 doi: 10.52927/jdcr.2024.12.2.115
|
| 94 |
Yiming Meng, Zhifu Yu, Yefeng Wu, Tianzhao Du, Shi Chen, Fanjuan Meng, Nan Su, Yushu Ma, Xiaoxi Li, Sulan Sun, Guirong Zhang. Cell-based immunotherapy with cytokine-induced killer (CIK) cells: From preparation and testing to clinical application. Human Vaccines & Immunotherapeutics 2017; 13(6): 1379 doi: 10.1080/21645515.2017.1285987
|
| 95 |
Solmaz Shirjang, Nazila Alizadeh, Behzad Mansoori, Ata Mahmoodpoor, Hossein Samadi Kafil, Mohammad Hojjat‐Farsangi, Mehdi Yousefi. Promising immunotherapy: Highlighting cytokine‐induced killer cells. Journal of Cellular Biochemistry 2019; 120(6): 8863 doi: 10.1002/jcb.28250
|
| 96 |
Cong-Guo Jin, Xiao-Qun Chen, Jia Li, Zhi-Pin Wu, Xin Liu, Xi-Cai Wang. Moderating Effects and Maintenance of Lung Cancer Cellular Immune Functions by CIK Cell Therapy. Asian Pacific Journal of Cancer Prevention 2013; 14(6): 3587 doi: 10.7314/APJCP.2013.14.6.3587
|
| 97 |
Hwan Mook Kim, Jaeseung Lim, Yeo Dae Yoon, Ji Mi Ahn, Jong Soon Kang, Kiho Lee, Song-Kyu Park, Yu Jin Jeong, Jin Mi Kim, Gyoonhee Han, Kyu-Hwan Yang, Yeon Jin Kim, Youngsoo Kim, Sang-Bae Han. Anti-tumor activity of ex vivo expanded cytokine-induced killer cells against human hepatocellular carcinoma. International Immunopharmacology 2007; 7(13): 1793 doi: 10.1016/j.intimp.2007.08.007
|
| 98 |
WEI LI, YAOMEI WANG, DANIEL B. KELLNER, LINGDI ZHAO, LINPING XU, QUANLI GAO. Efficacy of RetroNectin-activated cytokine-induced killer cell therapy in the treatment of advanced hepatocelluar carcinoma. Oncology Letters 2016; 12(1): 707 doi: 10.3892/ol.2016.4629
|